| Literature DB >> 35602769 |
Jae Woo Park1, Munjin Kim1, Sang Kuon Lee1.
Abstract
Purpose: The critical pathway (CP) was introduced as a means to provide quality healthcare service in many fields of surgery. CP may increase the patient's satisfaction rate and lowering hospital stay and medical cost also. We aimed to compare the two kinds of CP applied in laparoscopic cholecystectomy patients by different hospital stay length.Entities:
Keywords: Cholecystectomy; Critical pathways; Hospital costs; Laparoscopic
Year: 2019 PMID: 35602769 PMCID: PMC8980169 DOI: 10.7602/jmis.2019.22.2.69
Source DB: PubMed Journal: J Minim Invasive Surg
Inclusion and exclusion criteria for laparoscopic cholecystectomy CP
| Inclusion criteria | Exclusion criteria |
|---|---|
| Gallbladder stone, gallbladder polyp | Cholecystitis with complications (empyema, perforation) |
|
| |
| Admitted via out-patient department | Accompanied CBD stone |
|
| |
| Agreed with critical pathway | Emergency operation |
| ASA classification of 3 or more | |
| Open conversion | |
| Operative complication; biliary tract injury | |
| Refused to be discharged as scheduled | |
| Disagreed with critical pathway | |
ASA = American Society of Anesthesiologists; CBD = common bile duct.
Fig. 1Patients’ flow chart.
Patients’ preoperative characteristics comparing 2-day CP and 1-day CP
| All population (N=71) | 2-day CP (N=33) | 1-day CP (N=38) |
| |
|---|---|---|---|---|
| Age (years) | 0.472 | |||
| Mean (SD) | 50 (14) | 52 (13) | 49 (15) | |
| Median (range) | 48 (24~81) | 50 (31~78) | 46 (24~81) | |
|
| ||||
| Gender, N (%) | 0.295 | |||
| Male | 37 (52.1) | 15 (45.5) | 22 (57.9) | |
| Female | 34 (47.9) | 18 (55.5) | 16 (42.1) | |
|
| ||||
| Comorbidity
| 0.127 | |||
| Multiple comorbidities | 9 (12.7) | 7 (21.2) | 2 (5.3) | |
| One comorbidity | 25 (35.2) | 10 (30.3) | 15 (39.5) | |
| None | 37 (52.1) | 16 (48.5) | 21 (55.3) | |
|
| ||||
| Abdominal surgery, N (%) | 0.373 | |||
| Yes | 16 (22.5) | 9 (27.3) | 7 (18.4) | |
| No | 55 (77.5) | 24 (72.7) | 31 (81.6) | |
|
| ||||
| Pre-op ERCP, N (%) | 0.810 | |||
| Yes | 10 (14.1) | 5 (15.2) | 5 (13.2) | |
| No | 61 (85.9) | 28 (84.8) | 33 (86.8) | |
|
| ||||
| Diagnosis (pathologic), N (%) | 0.757 | |||
| Cholecystitis without stone | 22 (31.0) | 9 (27.3) | 13 (34.2) | |
| Cholecystitis with stone | 36 (50.7) | 18 (54.5) | 18 (47.4) | |
| Gallbladder polyp | 8 (11.3) | 3 (9.1) | 5 (13.2) | |
| Porcelain gallbladder | 1 (1.4) | 1 (3.0) | 0 (0.0) | |
| Xanthogranulomatosis | 4 (5.6) | 2 (6.1) | 2 (5.3) | |
CP = critical pathway; SD = standard deviation; ERCP = endoscopic retrograde cholangiopancreatography.
Including diabetes mellitus, hypertension, cerebrovascular accident, angina and systemic diseases regarded in ASA classification.
Comparison of operative outcomes of 2-day CP and 1-day CP
| All population (N=71) | 2-day CP (N=33) | 1-day CP (N=38) |
| |
|---|---|---|---|---|
| Port number, N (%) | 0.084 | |||
| Single port | 31 (43.7) | 18 (54.6) | 13 (34.2) | |
| Multiport | 40 (56.3) | 15 (45.4) | 25 (65.8) | |
|
| ||||
| Operation time (min) | <0.001 | |||
| Mean (SD) | 63.1 (23.5) | 73.4 (24.7) | 54.1 (18.4) | |
| Median (range) | 59 (25~125) | 70 (40~125) | 53 (25~96) | |
|
| ||||
| Complication, N (%) | 0.474 | |||
| Yes | 3 (4.2) | 2 (6.1) | 1 (2.6) | |
| No | 68 (95.8) | 31 (93.9) | 37 (97.4) | |
|
| ||||
| Pain scale, NRS | 0.052 | |||
| Mean (SD) | 2.00 (0.74) | 1.82 (0.64) | 2.16 (0.79) | |
| Median (range) | 2 (0~3) | 2 (0~3) | 2 (0~3) | |
|
| ||||
| Count of analgesics injection, N | 0.754 | |||
| Mean (SD) | 0.14 (0.49) | 0.12 (0.42) | 0.16 (0.55) | |
| Median (range) | 0 (0~3) | 0 (0~2) | 0 (0~3) | |
|
| ||||
| Outpatient follow-up laboratory values, Mean (SD) | ||||
| WBC (/mm3) | 6617 (1458) | 6494 (1537) | 6724 (1397) | 0.512 |
| Hemoglobin (g/dl) | 13.6 (1.2) | 13.5 (1.1) | 13.7 (1.4) | 0.604 |
| Total bilirubin (mg/dl) | 0.54 (0.32) | 0.54 (0.41) | 0.54 (0.24) | 0.995 |
| AST (IU/L) | 20.0 (9.2) | 18.3 (5.4) | 21.5 (11.4) | 0.137 |
| ALT (IU/L) | 24.9 (20.5) | 21.8 (12.4) | 27.7 (25.4) | 0.208 |
|
| ||||
| Total admission cost, ×104 won | 0.106 | |||
| Mean (SD) | 331.51 (34.23) | 347.04 (25.95) | 306.69 (29.80) | |
| Median (range) | 328.39 (267.85~398.47) | 343.95 (281.55~398.47) | 296.38 (267.85~385.00) | |
|
| ||||
| Actual patient’s expenditure, ×104 won | 0.276 | |||
| Mean (SD) | 138.03 (24.82) | 147.85 (20.67) | 125.58 (27.97) | |
| Median (range) | 137.04 (77.47~179.66) | 150.74 (89.86~189.66) | 122.66 (77.47~185.64) | |